Naproxen carries some cardiovascular risk, as all non-aspirin NSAIDs do, but it consistently ranks among the safest options in its class for heart health. The FDA requires a boxed warning on every NSAID label stating that these drugs can increase the chance of heart attack or stroke. That said, naproxen’s unique chemistry gives it a meaningful advantage over alternatives like ibuprofen and diclofenac.
Why Naproxen Is Easier on the Heart Than Other NSAIDs
All NSAIDs work by blocking enzymes called COX-1 and COX-2, which help produce chemicals involved in pain, inflammation, and blood vessel function. The cardiovascular trouble with most NSAIDs comes from blocking COX-2 too aggressively. COX-2 produces a substance called prostacyclin, which relaxes blood vessels and prevents blood cells from clumping together. When you suppress that protective mechanism without equally suppressing the clot-promoting signals driven by COX-1, you create conditions that favor blood clots.
Naproxen works differently from most NSAIDs because it’s about five times more selective for COX-1 than COX-2. That means it strongly suppresses platelet clumping, the same basic effect that makes low-dose aspirin protective for the heart. Its long half-life helps too: naproxen stays active in your system long enough to maintain that anti-clotting effect around the clock, something shorter-acting drugs like ibuprofen can’t do. Naproxen also doesn’t significantly raise systolic blood pressure, which further contributes to its relatively favorable heart profile.
The Actual Risk Numbers
The largest head-to-head trial comparing common NSAIDs, the PRECISION trial published in the New England Journal of Medicine, followed over 24,000 arthritis patients for an average of about 20 months. Cardiovascular events (heart attack, stroke, or cardiovascular death) occurred in 2.5% of patients taking naproxen, compared to 2.7% on ibuprofen and 2.3% on celecoxib. The differences between the three drugs were small enough to be statistically indistinguishable, meaning none was clearly worse or better than the others in this trial.
A separate large meta-analysis in the BMJ found that naproxen does raise heart attack risk early on. Within the first week of use, the odds of a heart attack increased by roughly 53% compared to not taking any NSAID. That sounds alarming, but context matters: a 53% increase on a very small baseline risk is still a small absolute risk for most people. Interestingly, the risk didn’t keep climbing with longer use. After 30 days, naproxen’s risk leveled off and no clear dose-response pattern was visible anymore, unlike ibuprofen, where higher doses continued to raise risk over time.
Doses above 750 mg per day during the first month of use appear particularly risky. At 750 mg per day or less taken for 8 to 30 days, there’s roughly a 58% probability that heart attack risk is modestly elevated (above an odds ratio of 1.20). In practical terms, this means keeping to the lowest effective dose matters most during the early weeks of use.
Effects on Blood Pressure
Naproxen can raise blood pressure, which is one indirect pathway through which it could stress the heart over time. At a standard dose of 500 mg twice daily, studies show an average increase of about 3.7 mmHg in systolic blood pressure and 2.0 mmHg in diastolic blood pressure after two weeks. In people who already have high blood pressure, meta-analyses of clinical trials suggest NSAIDs as a class can push mean arterial blood pressure up by 5 to 6 mmHg. That’s not a dramatic spike for a healthy person, but for someone already managing hypertension, it can be enough to undermine the effect of blood pressure medication.
Heart Failure Risk
A large nested case-control study across four European countries found that naproxen increased the odds of hospitalization for heart failure by 16%. That was the lowest increase among the seven traditional NSAIDs studied. For comparison, ketorolac (another NSAID) raised the odds by 83%. If you already have heart failure or reduced heart function, even a modest increase in fluid retention and blood pressure from any NSAID can push you toward a hospital visit, so the risk is more relevant for people with existing heart conditions than for healthy individuals.
The Aspirin Interaction Problem
If you take low-dose aspirin to protect your heart, naproxen can interfere with that protection. Aspirin works by permanently disabling COX-1 on platelets, preventing clots. Naproxen blocks the same enzyme, but only temporarily. If you take naproxen before your aspirin, it can physically block aspirin from reaching its target on platelets. The result: you lose the long-lasting anti-clot benefit aspirin provides.
The interaction is smaller if you take aspirin first and wait about two hours before taking naproxen. This gives aspirin time to lock onto platelets before naproxen competes for the same spot. If you’re on daily aspirin therapy for heart protection, timing matters.
How Naproxen Compares Overall
Among common over-the-counter pain relievers, naproxen has long been considered the least likely to cause cardiovascular problems. The PRECISION trial showed its event rates were similar to celecoxib and slightly better than ibuprofen, though the differences weren’t statistically significant. Its strong COX-1 inhibition gives it a mild aspirin-like anti-clotting property that other NSAIDs lack, and its minimal effect on blood pressure sets it apart from drugs like ibuprofen and diclofenac.
None of this makes naproxen heart-safe in an absolute sense. The FDA’s position is clear: all non-aspirin NSAIDs increase cardiovascular risk, the risk can appear within the first weeks of use, and it tends to increase at higher doses. The practical takeaway is to use the lowest dose that controls your pain, for the shortest time you need it. For occasional use in someone without heart disease, naproxen remains one of the more reasonable choices. For people with existing cardiovascular conditions, any NSAID use requires weighing the benefit of pain relief against a real, if modest, increase in heart risk.